Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer 2025-09-25 21:37
Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2) 2025-09-15 20:00
1